D

Deconib (Public limited company)

BE 0425.919.575 Active ●Aalterbaan 119, 9990 Maldegem

Deconib is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0425.919.575. It was founded on 21-12-1983. Its registered office is in Maldegem. Its main activity is: Financial service activities, except insurance and pension funding. Its annual accounts for 2025 report equity of € 3 286 445 and a profit of € 279 063. These accounts report 1 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 07-10-2026.

Company information

Status
Active
Enterprise number
BE 0425.919.575
VAT registered
Yes
Founded
21-12-1983
Latest accounts
2025
Employees
1 FTE
Region
Flanders
Establishments
1
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Aalterbaan 119, 9990 Maldegem
Main activity
Financial service activities, except insurance and pension funding
NACE activities
64210 Activités de société holding
73200 Études de marché et sondages
77320 Location et location-bail de machines et équipements pour la construction et le génie civil

Key figures of Deconib

202520242023
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ 279 063+38 %€ 202 738+18 %€ 171 100
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 3 286 445+9 %€ 3 007 382+7 %€ 2 804 645
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 9 653 750+7 %€ 9 063 258+10 %€ 8 271 023
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 1 210 334+5 %€ 1 150 667+11 %€ 1 038 777
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
10 %10 %1

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
2 mandates on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Maldegem.

CompanyTown
GEOFFROY VAN HULLE DECORATEUR 9990 Maldegem
Strybol De Rotonde 9990 Maldegem
PAGNAERT 9990 Maldegem
WIPAM 9990 Maldegem
AMELFI 9990 Maldegem
ARCETIS 9990 Maldegem
WILLEMS & PARTNERS 9990 Maldegem
Truweel Invest 9990 Maldegem
Looking for more information about Deconib?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is Deconib still active? Yes. The Crossroads Bank for Enterprises lists Deconib as active.

What is the VAT number of Deconib? The VAT number of Deconib is BE 0425.919.575.

When was Deconib founded? Deconib was founded on 21-12-1983.

What is the address of Deconib? The current registered office of Deconib is Aalterbaan 119, 9990 Maldegem.

When did Deconib last file annual accounts? The latest annual accounts of Deconib were filed on 29-08-2026.

Does Deconib file its annual accounts on time? Yes. Deconib filed its annual accounts within the legal deadline for each of its last 4 financial years.

How many employees does Deconib have? Deconib employs 1 full-time equivalents according to its most recent annual accounts.

Is Deconib financially healthy? Addrly gives Deconib a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is Deconib profitable? The annual accounts of Deconib for 2025 show a profit of € 279 063.

What is the equity of Deconib? The equity of Deconib was € 3 286 445 at the close of the 2025 financial year.

Who are the directors of Deconib? The annual accounts of Deconib record 2 mandates. The names, roles and dates are visible with a free account.

Can Deconib receive Peppol e-invoices? Yes. Deconib is registered on the Peppol network and can receive structured electronic invoices.

What does Deconib do? The main activity of Deconib is: Financial service activities, except insurance and pension funding.

Sources

How Addrly builds and refreshes this data